Acuvue Theravision with Ketotifen from Johnson & Johnson Vision is the first entry into an anticipated category of drug-eluting contact lenses.
Adding laboratory testing and meibography helps patients and practices
Some optometrists are reluctant to incorporate myopia control into practice. With global cases on the rise, the time to act is now.
At-home devices challenge commonly held beliefs on IOP measurements, visual field testing, and imaging.
Bridgitte Shen Lee, OD, FAAO, FBCLA, FEAOO, ponders about what she would like to see develop as both a researcher and a clinician in the dry eye space.
Cases illustrate how acute and chronic angle-closure glaucoma are treated
Presenters from the Collaborative Care Symposium 2025 give their key takeaways from their presentations.
What to know about legislative moves that have been made through May this year.
In this episode, four expert faculty talk about the importance of early diagnosis and treatment of thyroid eye disease. They discuss the differential diagnosis, screening tests, and the need for multidisciplinary management for these patients.
Austin Lifferth, OD, FAAO, shares highlights from his AAOpt 2022 presentations, including a triad approach to evaluating the optic nerve in glaucoma, and recentering glaucoma care with these 5 GlaucoMantras.
New technology improves precision of binocular vision disorder diagnosis and correction
This drug category is rapidly growing in the ophthalmic space, with more options in the pipeline
Collaboration between ophthalmologists, optometrists can boost early detection.
Jeffrey Anshel, OD, FAAO, outlines integrating nutritional supplements into patient eye care.
How eye care practices and doctors can prepare for the next pandemic
Neurofibromatosis type 1 (NF1) is a condition associated with significant systemic morbidity. Abnormal proliferation of cells derived from the neural crest can cause benign and malignant tumors throughout the body in NF1.
The Contact Lens Institute unveiled a preview of their data on contact lens patient retention at Vision Expo West. The full report will be released later this year.
Open Your Eyes documentary now available on Apple TV+ and Google Play!
Jay M. Haynie, OD, FAAO, FORS, caught up with Peg Achenbach, OD, FAAO, while at the 2023 Victoria Conference to share highlights from his presentation on staying current with the AMD landscape.
A single, consistent modality leads to better geographic atrophy tracking.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been recommending the NutriTears supplement to their dry eye patients.
A presbyopia-correcting eyedrop recently received FDA acceptance of its investigational new drug (IND) application
How eye care practices and doctors can prepare for the next pandemic
As the need for telemedicine increases, so does the urgency for creating new, less intrusive technology platforms.
Chris Kenrick, OD, shares what she finds to be most important from her discussion this year at AAOpt 2022.
Jamie Ho, OD, FAAO, FCOVD, shares highlights from her SCOPA 2022 presentation, "Tools and considerations for low vision rehabilitation."
Essence Johnson, OD, FAAO, addressed the "State of optometry," at NOA 2023 in Fort Lauderdale, Florida.
An inside look into a retrospective study conducted from 2019 to 2023 that aimed to assess the effectiveness of treatment and prevention of the progression of uncomplicated acquired myopia through physiotherapeutic methods.